About Journal of Hematology & Oncology

What is Journal of Hematology & Oncology?

Journal of Hematology & Oncology is an open access, peer-reviewed online journal that encompasses all aspects of hematology and oncology.

Hematology and oncology are closely intertwined and rapidly evolving fields. More physician scientists performing laboratory-based research are rapidly bringing research in hematology and oncology from bench to bedside. Journal of Hematology & Oncology aims to meet the demand for a journal dedicated to publishing discovery from both of these fields.

Journal of Hematology & Oncology aims to serve as an international platform for sharing laboratory and clinical findings in an open access format among laboratory scientists, physician scientists, hematologists and oncologists. A rapid turnaround time from submission to publication means that knowledge and new successes can be shared in real time.

Content overview

Journal of Hematology & Oncology considers the following types of articles:

• Research: reports of data from original research.
• Reviews: comprehensive, authoritative, descriptions of any subject within the journal's scope. Reviews can cover any topical themes such as basic science and clinical reviews, ethics, pro/con debates, equipment reviews and thematic series to highlight specific topics in the field.
• Case reports: reports of clinical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association, or present an important adverse reaction. These can also be used to present unexpected or unusual images of a disease. All case report articles should indicate that informed consent to publish the information was granted from the patients or their guardians.
• Letters to the Editor: brief laboratory and clinical studies should be submitted in this format for rapid communication. Reports of individual cases which may impact and /or enhance clinical practice or diagnostic understanding can also be submitted in this format. These can also take other forms: a substantial re-analysis of a previously published article, or a substantial response to such a re-analysis from the authors of the original publication, or an article that may not cover 'standard research' but that may be relevant to readers.
• Short reports: brief reports of data from original research.

Peer review policy

Journal of Hematology & Oncology has a 'closed' peer review policy. All submitted manuscripts will be screened before being sent to two peer reviewers. The Editor-in-Chief and Associate Editors are routinely involved in decision-making, but final decisions lie with the Editor-in-Chief. The journal aims to reach a first decision within six weeks. If an author has queries or is unhappy with a decision, there will be a discussion involving the Editor-in-Chief and at least one of the Associate Editors who were not involved in the initial reviewing.

Edited by Delong Liu, Journal of Hematology & Oncology is supported by an expert Editorial Board.

Publishing in Journal of Hematology & Oncology

All articles are listed in PubMed immediately upon acceptance (after peer review), and are covered by PubMed Central, MEDLINE, Thomson Reuters (ISI), CAS, Scopus and Current Contents.

Articles in Journal of Hematology & Oncology should be cited in the same way as articles in a traditional journal. However, because articles in this journal are not printed, they do not have page numbers. Instead, they have a unique article number.

The following citation:

J Hematol Oncol 2004, 2:1

refers to article 1 from volume 2 of the journal.

As an online journal, Journal of Hematology & Oncology does not have issue numbers. Each volume corresponds to a calendar year.

To keep up to date with the latest articles from Journal of Hematology & Oncology, why not register to receive alerts? Registration also enables you to customise your subject areas of interest, store your searches, and submit your manuscripts.

Submission of manuscripts

Manuscripts should be submitted electronically to Journal of Hematology & Oncology using the online submission system. Full details of how to submit a manuscript are given in the instructions for authors.

General journal policies

Journal of Hematology & Oncology is published by BioMed Central, part of Springer Science+Business Media. BioMed Central is committed to ensuring peer-reviewed biomedical research is open access. That means it is freely and universally accessible online, it is archived in at least one internationally recognised free access repository, and its authors retain copyright, allowing anyone to reproduce or disseminate articles, according to the BioMed Central copyright and licence agreement. Journal of Hematology & Oncology however, has taken this further by making all its content open access.

Journal of Hematology & Oncology's articles are archived in PubMed Central, the US National Library of Medicine's full-text repository of life science literature, and also at INIST in France and in e-Depot, the National Library of the Netherlands' digital archive of all electronic publications. The journal is also participating in the British Library's e-journals pilot project, and plans to deposit copies of all articles with the British Library.

Journal of Hematology & Oncology is able to deliver summaries of frequently updated content via Really Simple Syndication (RSS) feeds. These are accessible via the orange "XML" button at the top of the list of recent articles or the list of most accessed articles. For more information about RSS feeds see our publisher's website.

For further information about general policies please see the instructions for authors.